N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide

N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide is a synthetic small molecule belonging to the class of gamma amino acids and derivatives. It has a molecular formula of C24H22ClN5O2 and a molecular weight of approximately 447.9 g/mol[1][2][3]. The compound is not approved for clinical use by major regulatory agencies such as the FDA or EMA, and there are no registered clinical trials or known therapeutic indications for this molecule[5]. Its mechanism of action, pharmacological targets, and potential therapeutic applications have not been described in publicly available sources. It is considered an experimental drug candidate with possible pharmaceutical relevance but remains uncharacterized in terms of biological activity or disease association[8].

Other names

N-{5-[(2S)-4-amino-2-(3-chlorophenyl)butanamido]-1H-indazol-3-yl}benzamideBenzeneacetamide, alpha-(2-aminoethyl)-N-[3-(benzoylamino)-1H-indazol-5-yl]-3-chloro-, (alphaS)